Patrick Flynn alias Dr. Hidden Source Profit

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Cancer.

Cancer

Supports

No high-quality evidence in the provided index papers supports the standalone claim “Cancer. ” The only cancer-related indexed paper is a systematic review/meta-analysis on dose-dense adjuvant chemotherapy in breast cancer, which supports that some cancer treatments can improve outcomes in a specific setting, not the generic claim that “cancer” itself is established or supported as stated. ^{[1][2][3][4][5][6][7]}

Contradicts

The claim is too vague to be directly testable, and none of the listed index papers provide evidence for the broad proposition “Cancer. ” Most listed items are unrelated clinical trials or non-cancer topics, so they do not substantiate the claim. The evidence base provided is therefore insufficient for support, and the generic statement is not a meaningful medical claim without specifying a cancer type, intervention, diagnostic test, prognosis, or mechanism. The indexed review on dose-dense adjuvant chemotherapy addresses one breast-cancer treatment question only. ^{[1][2][3][4][5][6][7]}

Mainstream view

Cancer is a broad category of malignant diseases with established biological and clinical heterogeneity; mainstream oncology does not treat the bare word “Cancer” as a complete claim. A valid evidence-based assessment requires a specific cancer-related assertion, such as a treatment effect, screening benefit, diagnostic accuracy, risk factor, or prognosis. ^{[1][2][3][4][5][6][7]}

In their own wordsView sourceArchived copy

“Cancer”

Rule: Tex. Occ. Code §201.002(b)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Autoimmune.

Autoimmune

Supports

The influencer’s claim is too vague (“Autoimmune”) to evaluate directly, but high‑quality evidence strongly supports the general concept that autoimmune diseases are a large group of disorders caused by the immune system inappropriately attacking self‑tissues, leading to chronic inflammation and organ dysfunction.^{[1][11][14][19][22][23]} Multiple contemporary reviews and guidelines describe autoimmune diseases as heterogeneous, involving loss of immune tolerance, genetic predisposition (e.g., HLA variants), and environmental triggers such as infections, chemicals, and possibly gut microbiota changes.^{[1][3][7][11][14][19][22]} There is strong evidence that over 80–100 distinct autoimmune diseases have been identified and that, collectively, they affect several percent of the population (roughly 3–10%, with recent US estimates around 4–5%).^{[11][13][14][16][19][22]} Systematic reviews and RCTs support the use of established immunomodulatory therapies (e.g., glucocorticoids, disease‑modifying antirheumatic drugs, biologics such as TNF inhibitors) in specific autoimmune diseases, improving disease activity, symptoms, and organ outcomes.^{[4][5][12][19]} Newer targeted therapies, including stem cell–based approaches and microbiota‑based therapies, have RCT and systematic‑review level evidence showing potential benefit in selected autoimmune conditions, though these remain adjuncts or experimental rather than replacements for standard care.^[15][24]

Contradicts

Because the claim is not specific, there is no single high‑quality paper that contradicts the existence or basic nature of autoimmune diseases; rather, where evidence is weaker is in broad, simplified narratives that treat “autoimmune” as a single homogeneous condition with one cause or one universal treatment. Reviews emphasize substantial heterogeneity in pathogenesis, clinical manifestations, and treatment response among different autoimmune diseases.^{[1][3][11][14][19]} Evidence is also incomplete and sometimes conflicting regarding the precise contribution of environmental exposures (diet, chemicals, infections) and gut microbiota to autoimmunity: these factors are strongly suspected and supported by observational and mechanistic studies, but causal pathways and the effectiveness of broad microbiota‑modulating therapies are still being clarified.^{[7][15][18][19]} Stem cell therapies, CAR T‑cell approaches, helminth or schistosome‑based immunotherapies, and other novel interventions show promise in early trials and reviews, but current evidence is limited to specific diseases, small samples, and relatively short follow‑up, so they cannot be generalized as established cures for “autoimmune” conditions.^{[8][12][15][24]} Many authoritative overviews note that good incidence and prevalence data are still limited, and estimates vary between 3% and 10%, highlighting uncertainty rather than a definitive single prevalence figure.^[13][19][22]

Mainstream view

The mainstream medical view is that autoimmune diseases are a broad, heterogeneous group of more than 80–100 conditions in which the immune system loses self‑tolerance and attacks the body’s own cells, tissues, and organs, producing chronic inflammation and potentially serious morbidity.^{[1][3][11][14][19][22][23]} These diseases arise from an interplay of genetic susceptibility, environmental triggers, and dysregulated immune pathways, often involving autoreactive T and B cells and autoantibodies.^{[1][3][11][14][19][23]} Autoimmune diseases are recognized as common, affecting roughly several percent of the population worldwide, with a clear female predominance and increasing incidence over recent decades.^{[11][13][14][16][19][22]} Standard of care relies on evidence‑based immunomodulation (e.g., glucocorticoids, conventional DMARDs, biologics targeting cytokines or cells), tailored to each specific disease, with emerging but still largely experimental roles for stem cell transplantation, microbiota‑based therapies, and advanced cell therapies such as CAR T cells.^{[4][5][12][15][19][24]} Major guidelines and reviews emphasize early diagnosis, disease‑specific risk stratification, and long‑term, multidisciplinary management rather than any single universal therapy for “autoimmune” conditions.^{[4][5][11][19][23]} Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“Autoimmune”

Rule: Tex. Occ. Code §201.002(b)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Heart Disease.

Heart Disease

Supports

Strong evidence supports the broader claim that diet is a major driver of heart disease risk, but the index papers only support specific subclaims, not the vague statement "Heart Disease" itself. An umbrella review found added sugar intake is associated with worse cardiometabolic outcomes, including cardiovascular risk markers and adverse health outcomes, supporting concern about high-sugar diets . ^[16] The randomized-trial meta-analysis on fat replacement found that increasing polyunsaturated fat in place of saturated fat reduces coronary heart disease events, which supports a causal dietary prevention pathway . ^[17][23] The umbrella review and meta-analysis on adiposity found higher body fat is associated with higher cardiovascular outcomes risk, supporting obesity as a major heart disease risk factor . ^{[18][19][20][21][22]} Major cardiovascular guidance also states that poor diet quality, excess added sugar, and replacing saturated with polyunsaturated fat are linked to better cardiovascular health .

Contradicts

The evidence does not support the claim if it is intended as a standalone diagnosis or a specific treatment claim, because "Heart Disease" is too broad to be directly validated by the listed papers. The sugar umbrella review is about dietary sugar and health in general and does not establish that sugar alone causes all forms of heart disease; much of the evidence base for sugar is observational and vulnerable to confounding, so the causal certainty is lower than for randomized fat-replacement evidence . ^{[16][17][21][22][23]} The adiposity paper is an umbrella review of observational and Mendelian randomization studies, so it supports association more strongly than direct intervention benefit; it does not prove that weight loss alone will uniformly reduce every heart-disease outcome . ^[18] The congenital-anomalies review and the clinical trial listings are unrelated to heart disease, so they do not support the claim. ^[19] The overall evidence is strongest for reducing saturated fat by replacing it with polyunsaturated fat and for improving overall diet quality, not for a broad, unspecific claim about "heart disease" in general . ^[20]

Mainstream view

The mainstream medical view is that heart disease risk is influenced by multiple modifiable factors, including body fatness, diet quality, and dietary fat composition. ^{[16][18][19][21]} Current guidance generally supports reducing added sugars, avoiding excess calorie intake and obesity, and replacing saturated fat with polyunsaturated fat to lower coronary heart disease risk, while recognizing that the evidence is strongest for specific dietary substitutions and risk reduction rather than for broad slogans about "heart disease" . ^{[17][20][22][23]}

In their own wordsView sourceArchived copy

“Heart Disease”

Rule: Tex. Occ. Code §201.002(b)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Thyroid.

Thyroid

Supports

The influencer’s claim is too vague (“Thyroid”) to map directly onto one specific statement, but there is strong, high‑quality evidence and guideline consensus about major thyroid conditions (hypothyroidism, hyperthyroidism/Graves’ disease, thyroid nodules, thyroid cancer, subclinical hypothyroidism). For overt hypothyroidism, multiple guidelines and reviews conclude that daily oral levothyroxine monotherapy is the standard of care to normalize TSH and relieve symptoms.^{[5][12][15][17]} For hyperthyroidism (especially Graves’ disease), major reviews and guidelines consistently state that evidence‑based first‑line treatments are antithyroid drugs (methimazole/carbimazole or propylthiouracil), radioactive iodine, or thyroidectomy, individualized to the patient.^{[4][13][16][19][22][25]} Contemporary guidelines (e.g., NICE, American Thyroid Association, European Thyroid Association, AACE) provide structured, evidence‑based algorithms for evaluating and managing thyroid nodules and differentiated thyroid cancer, including indications for biopsy, surgery, and surveillance.^{[1][2][3][9][14][20][23]} High‑quality evidence and guidelines also support individualized management of subclinical hypothyroidism, with treatment generally reserved for TSH ≥10 mIU/L or specific high‑risk situations such as pregnancy, rather than routine thyroid hormone use for all mildly elevated TSH.^{[8][14][18][21]}

Contradicts

Because the influencer’s claim is unspecified, several common social‑media narratives about “thyroid” conflict with mainstream evidence. One frequent claim is that desiccated thyroid or T3‑containing combination therapy is generally superior to levothyroxine monotherapy; major guidelines explicitly state that levothyroxine alone remains the recommended therapy, and that evidence for routine use of thyroid extracts or LT4+LT3 combinations is insufficient and inconsistent.^[5][15][17] Another common claim is that any mildly elevated TSH (“subclinical hypothyroidism”) should always be treated with thyroid hormone; high‑quality guidelines and systematic‑review‑based recommendations advise against routine treatment for most adults with subclinical hypothyroidism because trials show little or no benefit in symptoms or quality of life, and potential harms, particularly in older adults.^{[8][14][18][21]} Some influencers imply that hyperthyroidism and Graves’ disease can be managed primarily with supplements, diet, or “natural” approaches; in contrast, established guidelines and reviews emphasize that controlling excess thyroid hormone with antithyroid drugs, radioactive iodine, or surgery is essential to prevent serious complications such as atrial fibrillation, osteoporosis, and thyroid storm.^{[4][13][16][19][22][25]} Claims that almost all fatigue, weight gain, or nonspecific symptoms are due to “thyroid” and should trigger thyroid hormone prescriptions for normal or near‑normal TSH are also inconsistent with guideline‑based diagnostic criteria and treatment thresholds.^{[14][15][17][21]}

Mainstream view

The mainstream medical position is that thyroid diseases are common, diverse, and should be diagnosed and treated according to well‑validated biochemical tests (TSH, free T4, and when appropriate thyroid antibodies, ultrasound, and cytology) rather than nonspecific symptoms alone.^{[14][15][17][20][23]} For overt hypothyroidism, the consensus is that lifelong oral levothyroxine monotherapy, titrated to normalize TSH and relieve symptoms, is the standard evidence‑based treatment; alternatives such as desiccated thyroid or LT4+LT3 combination therapy are reserved for selected cases within specialist care because robust data showing superiority are lacking.^{[5][12][15][17]} For hyperthyroidism and Graves’ disease, mainstream practice is to offer antithyroid drugs, radioactive iodine, or thyroidectomy as first‑line evidence‑based options, with beta‑blockers and supportive care for symptom control; choice among these is individualized based on age, comorbidities, pregnancy plans, goiter size, eye disease, and patient preference.^{[4][13][16][19][22][25]} Thyroid nodules and differentiated thyroid cancer are managed according to structured guideline algorithms using ultrasound risk stratification, fine‑needle aspiration, appropriate surgery, and long‑term surveillance, with an emphasis on avoiding both overtreatment and undertreatment.^{[1][2][3][9][20][23]} For subclinical hypothyroidism, mainstream guidelines recommend against routine thyroid hormone therapy in most nonpregnant adults, instead favoring individualized decisions, with clearer indications when TSH ≥10 mIU/L or in pregnancy or specific high‑risk contexts.^{[8][14][18][21]} Overall, mainstream clinicians rely on Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“Thyroid”

Rule: Tex. Occ. Code §201.002(b)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Diagnosing and treating cancer (oncology), which is outside chiropractic scope..

Diagnosing and treating cancer (oncology), which is outside chiropractic scope.

Supports

No high-quality evidence in the provided index papers supports the standalone claim “Cancer. ” The only cancer-related indexed paper is a systematic review/meta-analysis on dose-dense adjuvant chemotherapy in breast cancer, which supports that some cancer treatments can improve outcomes in a specific setting, not the generic claim that “cancer” itself is established or supported as stated. ^{[1][2][3][4][5][6][7]}

Contradicts

The claim is too vague to be directly testable, and none of the listed index papers provide evidence for the broad proposition “Cancer. ” Most listed items are unrelated clinical trials or non-cancer topics, so they do not substantiate the claim. The evidence base provided is therefore insufficient for support, and the generic statement is not a meaningful medical claim without specifying a cancer type, intervention, diagnostic test, prognosis, or mechanism. The indexed review on dose-dense adjuvant chemotherapy addresses one breast-cancer treatment question only. ^{[1][2][3][4][5][6][7]}

Mainstream view

Cancer is a broad category of malignant diseases with established biological and clinical heterogeneity; mainstream oncology does not treat the bare word “Cancer” as a complete claim. A valid evidence-based assessment requires a specific cancer-related assertion, such as a treatment effect, screening benefit, diagnostic accuracy, risk factor, or prognosis. ^{[1][2][3][4][5][6][7]}

In their own wordsView sourceArchived copy

“Cancer”

Rule: Tex. Occ. Code §201.002(b); §201.501(a)(1)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Diagnosing and treating autoimmune disease (immunology), which is outside chiropractic scope..

Diagnosing and treating autoimmune disease (immunology), which is outside chiropractic scope.

Supports

The influencer’s claim is too vague (“Autoimmune”) to evaluate directly, but high‑quality evidence strongly supports the general concept that autoimmune diseases are a large group of disorders caused by the immune system inappropriately attacking self‑tissues, leading to chronic inflammation and organ dysfunction.^{[1][11][14][19][22][23]} Multiple contemporary reviews and guidelines describe autoimmune diseases as heterogeneous, involving loss of immune tolerance, genetic predisposition (e.g., HLA variants), and environmental triggers such as infections, chemicals, and possibly gut microbiota changes.^{[1][3][7][11][14][19][22]} There is strong evidence that over 80–100 distinct autoimmune diseases have been identified and that, collectively, they affect several percent of the population (roughly 3–10%, with recent US estimates around 4–5%).^{[11][13][14][16][19][22]} Systematic reviews and RCTs support the use of established immunomodulatory therapies (e.g., glucocorticoids, disease‑modifying antirheumatic drugs, biologics such as TNF inhibitors) in specific autoimmune diseases, improving disease activity, symptoms, and organ outcomes.^{[4][5][12][19]} Newer targeted therapies, including stem cell–based approaches and microbiota‑based therapies, have RCT and systematic‑review level evidence showing potential benefit in selected autoimmune conditions, though these remain adjuncts or experimental rather than replacements for standard care.^[15][24]

Contradicts

Because the claim is not specific, there is no single high‑quality paper that contradicts the existence or basic nature of autoimmune diseases; rather, where evidence is weaker is in broad, simplified narratives that treat “autoimmune” as a single homogeneous condition with one cause or one universal treatment. Reviews emphasize substantial heterogeneity in pathogenesis, clinical manifestations, and treatment response among different autoimmune diseases.^{[1][3][11][14][19]} Evidence is also incomplete and sometimes conflicting regarding the precise contribution of environmental exposures (diet, chemicals, infections) and gut microbiota to autoimmunity: these factors are strongly suspected and supported by observational and mechanistic studies, but causal pathways and the effectiveness of broad microbiota‑modulating therapies are still being clarified.^{[7][15][18][19]} Stem cell therapies, CAR T‑cell approaches, helminth or schistosome‑based immunotherapies, and other novel interventions show promise in early trials and reviews, but current evidence is limited to specific diseases, small samples, and relatively short follow‑up, so they cannot be generalized as established cures for “autoimmune” conditions.^{[8][12][15][24]} Many authoritative overviews note that good incidence and prevalence data are still limited, and estimates vary between 3% and 10%, highlighting uncertainty rather than a definitive single prevalence figure.^[13][19][22]

Mainstream view

The mainstream medical view is that autoimmune diseases are a broad, heterogeneous group of more than 80–100 conditions in which the immune system loses self‑tolerance and attacks the body’s own cells, tissues, and organs, producing chronic inflammation and potentially serious morbidity.^{[1][3][11][14][19][22][23]} These diseases arise from an interplay of genetic susceptibility, environmental triggers, and dysregulated immune pathways, often involving autoreactive T and B cells and autoantibodies.^{[1][3][11][14][19][23]} Autoimmune diseases are recognized as common, affecting roughly several percent of the population worldwide, with a clear female predominance and increasing incidence over recent decades.^{[11][13][14][16][19][22]} Standard of care relies on evidence‑based immunomodulation (e.g., glucocorticoids, conventional DMARDs, biologics targeting cytokines or cells), tailored to each specific disease, with emerging but still largely experimental roles for stem cell transplantation, microbiota‑based therapies, and advanced cell therapies such as CAR T cells.^{[4][5][12][15][19][24]} Major guidelines and reviews emphasize early diagnosis, disease‑specific risk stratification, and long‑term, multidisciplinary management rather than any single universal therapy for “autoimmune” conditions.^{[4][5][11][19][23]} Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“Autoimmune”

Rule: Tex. Occ. Code §201.002(b)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Diagnosing and treating heart disease (cardiology), which is outside chiropractic scope..

Diagnosing and treating heart disease (cardiology), which is outside chiropractic scope.

Supports

Strong evidence supports the broader claim that diet is a major driver of heart disease risk, but the index papers only support specific subclaims, not the vague statement "Heart Disease" itself. An umbrella review found added sugar intake is associated with worse cardiometabolic outcomes, including cardiovascular risk markers and adverse health outcomes, supporting concern about high-sugar diets . ^[16] The randomized-trial meta-analysis on fat replacement found that increasing polyunsaturated fat in place of saturated fat reduces coronary heart disease events, which supports a causal dietary prevention pathway . ^[17][23] The umbrella review and meta-analysis on adiposity found higher body fat is associated with higher cardiovascular outcomes risk, supporting obesity as a major heart disease risk factor . ^{[18][19][20][21][22]} Major cardiovascular guidance also states that poor diet quality, excess added sugar, and replacing saturated with polyunsaturated fat are linked to better cardiovascular health .

Contradicts

The evidence does not support the claim if it is intended as a standalone diagnosis or a specific treatment claim, because "Heart Disease" is too broad to be directly validated by the listed papers. The sugar umbrella review is about dietary sugar and health in general and does not establish that sugar alone causes all forms of heart disease; much of the evidence base for sugar is observational and vulnerable to confounding, so the causal certainty is lower than for randomized fat-replacement evidence . ^{[16][17][21][22][23]} The adiposity paper is an umbrella review of observational and Mendelian randomization studies, so it supports association more strongly than direct intervention benefit; it does not prove that weight loss alone will uniformly reduce every heart-disease outcome . ^[18] The congenital-anomalies review and the clinical trial listings are unrelated to heart disease, so they do not support the claim. ^[19] The overall evidence is strongest for reducing saturated fat by replacing it with polyunsaturated fat and for improving overall diet quality, not for a broad, unspecific claim about "heart disease" in general . ^[20]

Mainstream view

The mainstream medical view is that heart disease risk is influenced by multiple modifiable factors, including body fatness, diet quality, and dietary fat composition. ^{[16][18][19][21]} Current guidance generally supports reducing added sugars, avoiding excess calorie intake and obesity, and replacing saturated fat with polyunsaturated fat to lower coronary heart disease risk, while recognizing that the evidence is strongest for specific dietary substitutions and risk reduction rather than for broad slogans about "heart disease" . ^{[17][20][22][23]}

In their own wordsView sourceArchived copy

“Heart Disease”

Rule: Tex. Occ. Code §201.002(b)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Diagnosing and treating thyroid disease (endocrinology), which is outside chiropractic scope..

Diagnosing and treating thyroid disease (endocrinology), which is outside chiropractic scope.

Supports

The influencer’s claim is too vague (“Thyroid”) to map directly onto one specific statement, but there is strong, high‑quality evidence and guideline consensus about major thyroid conditions (hypothyroidism, hyperthyroidism/Graves’ disease, thyroid nodules, thyroid cancer, subclinical hypothyroidism). For overt hypothyroidism, multiple guidelines and reviews conclude that daily oral levothyroxine monotherapy is the standard of care to normalize TSH and relieve symptoms.^{[5][12][15][17]} For hyperthyroidism (especially Graves’ disease), major reviews and guidelines consistently state that evidence‑based first‑line treatments are antithyroid drugs (methimazole/carbimazole or propylthiouracil), radioactive iodine, or thyroidectomy, individualized to the patient.^{[4][13][16][19][22][25]} Contemporary guidelines (e.g., NICE, American Thyroid Association, European Thyroid Association, AACE) provide structured, evidence‑based algorithms for evaluating and managing thyroid nodules and differentiated thyroid cancer, including indications for biopsy, surgery, and surveillance.^{[1][2][3][9][14][20][23]} High‑quality evidence and guidelines also support individualized management of subclinical hypothyroidism, with treatment generally reserved for TSH ≥10 mIU/L or specific high‑risk situations such as pregnancy, rather than routine thyroid hormone use for all mildly elevated TSH.^{[8][14][18][21]}

Contradicts

Because the influencer’s claim is unspecified, several common social‑media narratives about “thyroid” conflict with mainstream evidence. One frequent claim is that desiccated thyroid or T3‑containing combination therapy is generally superior to levothyroxine monotherapy; major guidelines explicitly state that levothyroxine alone remains the recommended therapy, and that evidence for routine use of thyroid extracts or LT4+LT3 combinations is insufficient and inconsistent.^[5][15][17] Another common claim is that any mildly elevated TSH (“subclinical hypothyroidism”) should always be treated with thyroid hormone; high‑quality guidelines and systematic‑review‑based recommendations advise against routine treatment for most adults with subclinical hypothyroidism because trials show little or no benefit in symptoms or quality of life, and potential harms, particularly in older adults.^{[8][14][18][21]} Some influencers imply that hyperthyroidism and Graves’ disease can be managed primarily with supplements, diet, or “natural” approaches; in contrast, established guidelines and reviews emphasize that controlling excess thyroid hormone with antithyroid drugs, radioactive iodine, or surgery is essential to prevent serious complications such as atrial fibrillation, osteoporosis, and thyroid storm.^{[4][13][16][19][22][25]} Claims that almost all fatigue, weight gain, or nonspecific symptoms are due to “thyroid” and should trigger thyroid hormone prescriptions for normal or near‑normal TSH are also inconsistent with guideline‑based diagnostic criteria and treatment thresholds.^{[14][15][17][21]}

Mainstream view

The mainstream medical position is that thyroid diseases are common, diverse, and should be diagnosed and treated according to well‑validated biochemical tests (TSH, free T4, and when appropriate thyroid antibodies, ultrasound, and cytology) rather than nonspecific symptoms alone.^{[14][15][17][20][23]} For overt hypothyroidism, the consensus is that lifelong oral levothyroxine monotherapy, titrated to normalize TSH and relieve symptoms, is the standard evidence‑based treatment; alternatives such as desiccated thyroid or LT4+LT3 combination therapy are reserved for selected cases within specialist care because robust data showing superiority are lacking.^{[5][12][15][17]} For hyperthyroidism and Graves’ disease, mainstream practice is to offer antithyroid drugs, radioactive iodine, or thyroidectomy as first‑line evidence‑based options, with beta‑blockers and supportive care for symptom control; choice among these is individualized based on age, comorbidities, pregnancy plans, goiter size, eye disease, and patient preference.^{[4][13][16][19][22][25]} Thyroid nodules and differentiated thyroid cancer are managed according to structured guideline algorithms using ultrasound risk stratification, fine‑needle aspiration, appropriate surgery, and long‑term surveillance, with an emphasis on avoiding both overtreatment and undertreatment.^{[1][2][3][9][20][23]} For subclinical hypothyroidism, mainstream guidelines recommend against routine thyroid hormone therapy in most nonpregnant adults, instead favoring individualized decisions, with clearer indications when TSH ≥10 mIU/L or in pregnancy or specific high‑risk contexts.^{[8][14][18][21]} Overall, mainstream clinicians rely on Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“Thyroid”

Rule: Tex. Occ. Code §201.002(b)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Treatment of Cancer.

Treatment of Cancer

Supports

No high-quality evidence in the provided index papers supports the standalone claim “Cancer. ” The only cancer-related indexed paper is a systematic review/meta-analysis on dose-dense adjuvant chemotherapy in breast cancer, which supports that some cancer treatments can improve outcomes in a specific setting, not the generic claim that “cancer” itself is established or supported as stated. ^{[1][2][3][4][5][6][7]}

Contradicts

The claim is too vague to be directly testable, and none of the listed index papers provide evidence for the broad proposition “Cancer. ” Most listed items are unrelated clinical trials or non-cancer topics, so they do not substantiate the claim. The evidence base provided is therefore insufficient for support, and the generic statement is not a meaningful medical claim without specifying a cancer type, intervention, diagnostic test, prognosis, or mechanism. The indexed review on dose-dense adjuvant chemotherapy addresses one breast-cancer treatment question only. ^{[1][2][3][4][5][6][7]}

Mainstream view

Cancer is a broad category of malignant diseases with established biological and clinical heterogeneity; mainstream oncology does not treat the bare word “Cancer” as a complete claim. A valid evidence-based assessment requires a specific cancer-related assertion, such as a treatment effect, screening benefit, diagnostic accuracy, risk factor, or prognosis. ^{[1][2][3][4][5][6][7]}

In their own wordsView sourceArchived copy

“Cancer”

Rule: Tex. Occ. Code §201.002(b)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Treatment of Autoimmune Disease.

Treatment of Autoimmune Disease

Supports

The influencer’s claim is too vague (“Autoimmune”) to evaluate directly, but high‑quality evidence strongly supports the general concept that autoimmune diseases are a large group of disorders caused by the immune system inappropriately attacking self‑tissues, leading to chronic inflammation and organ dysfunction.^{[1][11][14][19][22][23]} Multiple contemporary reviews and guidelines describe autoimmune diseases as heterogeneous, involving loss of immune tolerance, genetic predisposition (e.g., HLA variants), and environmental triggers such as infections, chemicals, and possibly gut microbiota changes.^{[1][3][7][11][14][19][22]} There is strong evidence that over 80–100 distinct autoimmune diseases have been identified and that, collectively, they affect several percent of the population (roughly 3–10%, with recent US estimates around 4–5%).^{[11][13][14][16][19][22]} Systematic reviews and RCTs support the use of established immunomodulatory therapies (e.g., glucocorticoids, disease‑modifying antirheumatic drugs, biologics such as TNF inhibitors) in specific autoimmune diseases, improving disease activity, symptoms, and organ outcomes.^{[4][5][12][19]} Newer targeted therapies, including stem cell–based approaches and microbiota‑based therapies, have RCT and systematic‑review level evidence showing potential benefit in selected autoimmune conditions, though these remain adjuncts or experimental rather than replacements for standard care.^[15][24]

Contradicts

Because the claim is not specific, there is no single high‑quality paper that contradicts the existence or basic nature of autoimmune diseases; rather, where evidence is weaker is in broad, simplified narratives that treat “autoimmune” as a single homogeneous condition with one cause or one universal treatment. Reviews emphasize substantial heterogeneity in pathogenesis, clinical manifestations, and treatment response among different autoimmune diseases.^{[1][3][11][14][19]} Evidence is also incomplete and sometimes conflicting regarding the precise contribution of environmental exposures (diet, chemicals, infections) and gut microbiota to autoimmunity: these factors are strongly suspected and supported by observational and mechanistic studies, but causal pathways and the effectiveness of broad microbiota‑modulating therapies are still being clarified.^{[7][15][18][19]} Stem cell therapies, CAR T‑cell approaches, helminth or schistosome‑based immunotherapies, and other novel interventions show promise in early trials and reviews, but current evidence is limited to specific diseases, small samples, and relatively short follow‑up, so they cannot be generalized as established cures for “autoimmune” conditions.^{[8][12][15][24]} Many authoritative overviews note that good incidence and prevalence data are still limited, and estimates vary between 3% and 10%, highlighting uncertainty rather than a definitive single prevalence figure.^[13][19][22]

Mainstream view

The mainstream medical view is that autoimmune diseases are a broad, heterogeneous group of more than 80–100 conditions in which the immune system loses self‑tolerance and attacks the body’s own cells, tissues, and organs, producing chronic inflammation and potentially serious morbidity.^{[1][3][11][14][19][22][23]} These diseases arise from an interplay of genetic susceptibility, environmental triggers, and dysregulated immune pathways, often involving autoreactive T and B cells and autoantibodies.^{[1][3][11][14][19][23]} Autoimmune diseases are recognized as common, affecting roughly several percent of the population worldwide, with a clear female predominance and increasing incidence over recent decades.^{[11][13][14][16][19][22]} Standard of care relies on evidence‑based immunomodulation (e.g., glucocorticoids, conventional DMARDs, biologics targeting cytokines or cells), tailored to each specific disease, with emerging but still largely experimental roles for stem cell transplantation, microbiota‑based therapies, and advanced cell therapies such as CAR T cells.^{[4][5][12][15][19][24]} Major guidelines and reviews emphasize early diagnosis, disease‑specific risk stratification, and long‑term, multidisciplinary management rather than any single universal therapy for “autoimmune” conditions.^{[4][5][11][19][23]} Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“Autoimmune”

Rule: Tex. Occ. Code §201.002(b)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Treatment of Heart Disease.

Treatment of Heart Disease

Supports

Strong evidence supports the broader claim that diet is a major driver of heart disease risk, but the index papers only support specific subclaims, not the vague statement "Heart Disease" itself. An umbrella review found added sugar intake is associated with worse cardiometabolic outcomes, including cardiovascular risk markers and adverse health outcomes, supporting concern about high-sugar diets . ^[16] The randomized-trial meta-analysis on fat replacement found that increasing polyunsaturated fat in place of saturated fat reduces coronary heart disease events, which supports a causal dietary prevention pathway . ^[17][23] The umbrella review and meta-analysis on adiposity found higher body fat is associated with higher cardiovascular outcomes risk, supporting obesity as a major heart disease risk factor . ^{[18][19][20][21][22]} Major cardiovascular guidance also states that poor diet quality, excess added sugar, and replacing saturated with polyunsaturated fat are linked to better cardiovascular health .

Contradicts

The evidence does not support the claim if it is intended as a standalone diagnosis or a specific treatment claim, because "Heart Disease" is too broad to be directly validated by the listed papers. The sugar umbrella review is about dietary sugar and health in general and does not establish that sugar alone causes all forms of heart disease; much of the evidence base for sugar is observational and vulnerable to confounding, so the causal certainty is lower than for randomized fat-replacement evidence . ^{[16][17][21][22][23]} The adiposity paper is an umbrella review of observational and Mendelian randomization studies, so it supports association more strongly than direct intervention benefit; it does not prove that weight loss alone will uniformly reduce every heart-disease outcome . ^[18] The congenital-anomalies review and the clinical trial listings are unrelated to heart disease, so they do not support the claim. ^[19] The overall evidence is strongest for reducing saturated fat by replacing it with polyunsaturated fat and for improving overall diet quality, not for a broad, unspecific claim about "heart disease" in general . ^[20]

Mainstream view

The mainstream medical view is that heart disease risk is influenced by multiple modifiable factors, including body fatness, diet quality, and dietary fat composition. ^{[16][18][19][21]} Current guidance generally supports reducing added sugars, avoiding excess calorie intake and obesity, and replacing saturated fat with polyunsaturated fat to lower coronary heart disease risk, while recognizing that the evidence is strongest for specific dietary substitutions and risk reduction rather than for broad slogans about "heart disease" . ^{[17][20][22][23]}

In their own wordsView sourceArchived copy

“Heart Disease”

Rule: Tex. Occ. Code §201.002(b)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Hormone Imbalances.

Hormone Imbalances

Supports

High-quality evidence clearly shows that specific, objectively defined hormonal imbalances (e. g. , hypothyroidism, hyperthyroidism, diabetes, adrenal insufficiency, hypogonadism, menopause, polycystic ovary syndrome, hypoparathyroidism) are real, common, and clinically important, and that correcting documented deficiencies or excesses with hormone therapy can improve symptoms and reduce complications. ^[35] Large epidemiologic and review papers on endocrine disorders describe “hormonal disorders” and “hormonal imbalances” as major global health problems when these terms refer to specific glandular diseases with abnormal hormone levels, such as thyroid disease, diabetes, and reproductive hormone disorders. ^[37][38] Authoritative guidance on menopausal hormone therapy states that a core principle of endocrinology is to replace hormones only after establishing a biologically important deficiency state, implying that targeted treatment of documented hormone imbalance is appropriate and evidence‑based in those settings. ^[36] There are systematic reviews and meta-analyses showing that parathyroid hormone therapy is effective in chronic hypoparathyroidism, a clear example of treating a specific hormone deficiency to correct an imbalance and improve biochemical control and quality of life. Narrative and systematic reviews on endocrine disorders and related conditions (e. g. , breast cancer, arrhythmias, psychiatric outcomes) consistently recognize that abnormal hormone levels can causally contribute to disease processes and that evidence-based hormone modulation is an important component of management in selected, clearly defined cases.

Contradicts

There is no high-quality evidence supporting the broad, non-specific influencer claim that a vague “hormone imbalance” is the root cause of most common symptoms (fatigue, weight gain, brain fog, low mood, etc. ^[35] ) in generally healthy people without objective endocrine abnormalities; major guidelines instead require clear biochemical and clinical criteria for diagnosing endocrine disease. ^[38] Editorials and position-type articles in endocrinology literature describe how some practitioners and marketers have invented pseudo-diseases and misused hormone therapy, warning that this departs from evidence-based endocrinology and can expose patients to unnecessary risk. Major women’s health and endocrine organizations, as well as regulatory agencies, explicitly state that heavily promoted compounded or “bioidentical” hormone regimens marketed for generalized “hormone imbalance” have not been shown in randomized trials or robust observational studies to be safer or more effective than standard, regulated hormone therapies, and that the many broad health claims made for them remain unsubstantiated. High-quality reviews emphasize that even when hormonal changes contribute to symptoms (e. g. , perimenopause, menstrual cycle variation, stress-related cortisol changes), these fluctuations are often normal physiology rather than a pathological “imbalance,” and that treatment should be symptom-targeted and individualized rather than based on non-validated saliva panels or broad marketing claims. Systematic and narrative reviews on endocrine disorders repeatedly stress that hormone therapy should be used to treat specific diagnosed conditions (e. ^[37] g. , chronic hypoparathyroidism, documented hypogonadism) rather than to normalize numbers in people without clear clinical disease, and that overprescription of hormones carries risks such as cardiovascular events, cancers, and thromboembolism. ^[36]

Mainstream view

The mainstream medical view is that “hormone imbalance” is a meaningful concept only when it refers to specific, objectively demonstrated endocrine disorders (e. ^[35][37][38] g. , thyroid disease, diabetes, adrenal insufficiency, hypoparathyroidism, PCOS, menopause with significant symptoms) defined by characteristic clinical features plus validated laboratory abnormalities. In these well-defined conditions, guidelines and high-quality reviews support targeted use of hormone replacement or suppression therapy to restore levels toward a physiological range and improve outcomes, with careful attention to risk–benefit balance and ongoing monitoring. ^[36] Mainstream endocrinology explicitly rejects the non-specific influencer framing of “hormone imbalance” as a catch‑all diagnosis for common, poorly defined symptoms in otherwise healthy people, and it warns against routine use of unregulated or compounded hormone products, or extensive non-validated testing, in the absence Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“Hormone Imbalances”

Rule: Tex. Occ. Code §201.002(b)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Digestive Issues.

Digestive Issues

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Digestive Issues”

Rule: Tex. Occ. Code §201.002(b)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Allergies.

Allergies

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Allergies”

Rule: Tex. Occ. Code §201.002(b)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Mood Disorders.

Mood Disorders

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Mood Disorders”

Rule: Tex. Occ. Code §201.002(b)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to advertise Learn More About Our Approach as within their scope of practice.

Learn More About Our Approach

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Learn More About Our Approach”

Rule: State Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure View All Conditions.

View All Conditions

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“View All Conditions”

Rule: State Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Patrick Flynn is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Treatment of Hormone Imbalances.

Treatment of Hormone Imbalances

Supports

High-quality evidence clearly shows that specific, objectively defined hormonal imbalances (e. g. , hypothyroidism, hyperthyroidism, diabetes, adrenal insufficiency, hypogonadism, menopause, polycystic ovary syndrome, hypoparathyroidism) are real, common, and clinically important, and that correcting documented deficiencies or excesses with hormone therapy can improve symptoms and reduce complications. ^[35] Large epidemiologic and review papers on endocrine disorders describe “hormonal disorders” and “hormonal imbalances” as major global health problems when these terms refer to specific glandular diseases with abnormal hormone levels, such as thyroid disease, diabetes, and reproductive hormone disorders. ^[37][38] Authoritative guidance on menopausal hormone therapy states that a core principle of endocrinology is to replace hormones only after establishing a biologically important deficiency state, implying that targeted treatment of documented hormone imbalance is appropriate and evidence‑based in those settings. ^[36] There are systematic reviews and meta-analyses showing that parathyroid hormone therapy is effective in chronic hypoparathyroidism, a clear example of treating a specific hormone deficiency to correct an imbalance and improve biochemical control and quality of life. Narrative and systematic reviews on endocrine disorders and related conditions (e. g. , breast cancer, arrhythmias, psychiatric outcomes) consistently recognize that abnormal hormone levels can causally contribute to disease processes and that evidence-based hormone modulation is an important component of management in selected, clearly defined cases.

Contradicts

There is no high-quality evidence supporting the broad, non-specific influencer claim that a vague “hormone imbalance” is the root cause of most common symptoms (fatigue, weight gain, brain fog, low mood, etc. ^[35] ) in generally healthy people without objective endocrine abnormalities; major guidelines instead require clear biochemical and clinical criteria for diagnosing endocrine disease. ^[38] Editorials and position-type articles in endocrinology literature describe how some practitioners and marketers have invented pseudo-diseases and misused hormone therapy, warning that this departs from evidence-based endocrinology and can expose patients to unnecessary risk. Major women’s health and endocrine organizations, as well as regulatory agencies, explicitly state that heavily promoted compounded or “bioidentical” hormone regimens marketed for generalized “hormone imbalance” have not been shown in randomized trials or robust observational studies to be safer or more effective than standard, regulated hormone therapies, and that the many broad health claims made for them remain unsubstantiated. High-quality reviews emphasize that even when hormonal changes contribute to symptoms (e. g. , perimenopause, menstrual cycle variation, stress-related cortisol changes), these fluctuations are often normal physiology rather than a pathological “imbalance,” and that treatment should be symptom-targeted and individualized rather than based on non-validated saliva panels or broad marketing claims. Systematic and narrative reviews on endocrine disorders repeatedly stress that hormone therapy should be used to treat specific diagnosed conditions (e. ^[37] g. , chronic hypoparathyroidism, documented hypogonadism) rather than to normalize numbers in people without clear clinical disease, and that overprescription of hormones carries risks such as cardiovascular events, cancers, and thromboembolism. ^[36]

Mainstream view

The mainstream medical view is that “hormone imbalance” is a meaningful concept only when it refers to specific, objectively demonstrated endocrine disorders (e. ^[35][37][38] g. , thyroid disease, diabetes, adrenal insufficiency, hypoparathyroidism, PCOS, menopause with significant symptoms) defined by characteristic clinical features plus validated laboratory abnormalities. In these well-defined conditions, guidelines and high-quality reviews support targeted use of hormone replacement or suppression therapy to restore levels toward a physiological range and improve outcomes, with careful attention to risk–benefit balance and ongoing monitoring. ^[36] Mainstream endocrinology explicitly rejects the non-specific influencer framing of “hormone imbalance” as a catch‑all diagnosis for common, poorly defined symptoms in otherwise healthy people, and it warns against routine use of unregulated or compounded hormone products, or extensive non-validated testing, in the absence Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“Hormone Imbalances”

Rule: State Chiropractic Practice Act (scope limited to musculoskeletal/spine care)